0001209191-23-057558.txt : 20231205 0001209191-23-057558.hdr.sgml : 20231205 20231205200013 ACCESSION NUMBER: 0001209191-23-057558 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arif Bilal CENTRAL INDEX KEY: 0001959750 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 231468201 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-01 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001959750 Arif Bilal 215 FIRST STREET CAMBRIDGE MA 02129 0 1 0 0 Chief Tech Ops Officer 0 Common Stock 2023-12-01 4 F 0 3682 80.34 D 22886 D Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021. Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2023. /s/ Ryan Brown, as Attorney-in-Fact for Bilal Arif 2023-12-05